---
document_datetime: 2023-09-21 19:15:17
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/docefrez-epar-all-authorised-presentations_en.pdf
document_name: docefrez-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7764791
conversion_datetime: 2025-12-27 20:53:05.306481
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU-number       | Name     | Strength   | Pharmaceutical form                                          | Route of Administration   | Packaging                                  | Content                                                | Package size    |
|-----------------|----------|------------|--------------------------------------------------------------|---------------------------|--------------------------------------------|--------------------------------------------------------|-----------------|
| EU/1/10/630/001 | Docefrez | 20 mg      | powder and solvent for concentrate for solution for infusion | Intravenous use           | Powder: vial (glass) Solvent: vial (glass) | authorised (concentration) Powder: 20 mg Solvent: 1 ml | 1 vial + 1 vial |
| EU/1/10/630/002 | Docefrez | 80 mg      | powder and solvent for concentrate for solution for infusion | Intravenous use           | Powder: vial (glass) Solvent: vial (glass) | Powder: 80 mg Solvent: 4ml                             | 1 vial + 1 vial |

<!-- image -->